HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

KRRO

Korro Bio Inc

Last Close
Dec 11 • 04:00PM ET
48.69
Dollar change
+1.94
Percentage change
4.15 		%
Healthcare • Biotechnology • USA • NASD
Peers: BEAM EDIT NTLA CRSP RGNX FDMT VYGR ARVN SGMO CRBU
 | Held by: VTI IWM VXF IWN VTWO VHT IWO IWC ITOT VTWV
Scroll to Statements
IndexRUT P/E- EPS (ttm)-12.02 Insider Own40.57% Shs Outstand9.32M Perf Week26.11%
Market Cap456.14M Forward P/E- EPS next Y-9.74 Insider Trans-0.29% Shs Float5.57M Perf Month-33.76%
Income-101.60M PEG- EPS next Q-2.57 Inst Own59.06% Short Float5.39% Perf Quarter20.40%
Sales0.00M P/S- EPS this Y82.53% Inst Trans2.64% Short Ratio2.22 Perf Half Y14.27%
Book/sh19.28 P/B2.53 EPS next Y-5.10% ROA-70.10% Short Interest0.30M Perf Year-2.76%
Cash/sh14.81 P/C3.29 EPS next 5Y- ROE-93.91% 52W Range30.00 - 98.00 Perf YTD1.59%
Dividend Est.- P/FCF- EPS past 5Y-11.67% ROI-45.89% 52W High-50.32% Beta3.65
Dividend TTM- Quick Ratio11.23 Sales past 5Y-26.84% Gross Margin- 52W Low62.27% ATR (14)6.51
Dividend Ex-Date- Current Ratio11.23 EPS Y/Y TTM85.54% Oper. Margin- RSI (14)47.39 Volatility14.58% 13.58%
Employees101 Debt/Eq0.23 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price133.83
Option/ShortNo / Yes LT Debt/Eq0.23 EPS Q/Q85.65% Payout- Rel Volume1.24 Prev Close46.75
Sales Surprise- EPS Surprise10.56% Sales Q/Q- EarningsNov 12 AMC Avg Volume135.09K Price48.69
SMA200.18% SMA50-9.56% SMA200-4.93% Trades Volume164,616 Change4.15%
Date Action Analyst Rating Change Price Target Change
Oct-21-24Initiated Raymond James Strong Buy $153
Aug-14-24Initiated William Blair Outperform $180
Mar-28-24Reiterated H.C. Wainwright Buy $100 → $115
Feb-27-24Initiated BMO Capital Markets Outperform $120
Dec-04-23Initiated H.C. Wainwright Buy $100
Nov-29-23Initiated RBC Capital Mkts Outperform $70
Nov-10-23Initiated Piper Sandler Overweight $180
Feb-15-23Downgrade Chardan Capital Markets Buy → Neutral
Feb-13-23Downgrade Cowen Outperform → Market Perform
Sep-22-21Downgrade Goldman Buy → Neutral $12 → $9
Show Previous Ratings
Dec-10-24 08:00AM
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
(GlobeNewswire)
Nov-21-24 04:01PM
Korro to Participate in Upcoming Investor Conferences
(GlobeNewswire) +7.70%
07:30AM
Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
(GlobeNewswire)
Nov-14-24 08:00AM
Korro to Present at the Jefferies London Healthcare Conference
(GlobeNewswire) -9.65%
Nov-12-24 04:05PM
Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates
(GlobeNewswire) -11.37% -15.55%
07:25AM Loading…
Nov-04-24 07:25AM
Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board
(GlobeNewswire)
Oct-21-24 04:15PM
Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
(Investor's Business Daily) -5.22% -7.70%
Oct-16-24 04:20PM
Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
(Investor's Business Daily) +93.66%
Sep-30-24 08:00AM
Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society
(GlobeNewswire)
Sep-16-24 08:00AM
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
(GlobeNewswire)
Sep-10-24 08:00AM
Korro to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Aug-28-24 08:00AM
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
(GlobeNewswire)
Aug-27-24 08:00AM
Korro to Participate in Upcoming September Investor and Scientific Conferences
(GlobeNewswire)
Aug-13-24 04:01PM
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates
(GlobeNewswire) +9.21%
Jul-01-24 08:00AM
Korro Joins the Russell 2000 , Russell 3000 , and Russell Microcap Indexes
(GlobeNewswire)
12:53PM Loading…
Jun-25-24 12:53PM
KRRO Stock Earnings: Korro Bio Beats EPS for Q4 2023
(InvestorPlace)
May-30-24 04:01PM
Korro to Participate in Upcoming June Investor and Scientific Conferences
(GlobeNewswire)
May-20-24 02:30PM
Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International Conference
(GlobeNewswire)
May-14-24 10:55PM
KRRO Stock Earnings: Korro Bio Beats EPS for Q1 2024
(InvestorPlace) +5.43%
04:01PM
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer
(GlobeNewswire)
Apr-18-24 08:30AM
Korro Announces $70 Million Private Placement
(GlobeNewswire)
Apr-01-24 04:01PM
Korro to Participate in Upcoming Investor Conferences
(GlobeNewswire) -7.90%
Mar-26-24 04:01PM
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress
(GlobeNewswire) +18.43%
Feb-27-24 09:55AM
Wall Street Analysts Believe Korro Bio, Inc. (KRRO) Could Rally 86.94%: Here's is How to Trade
(Zacks) -6.08%
08:00AM
Korro to Present at the TD Cowen 44th Annual Health Care Conference
(GlobeNewswire)
Feb-09-24 09:55AM
Does Korro Bio, Inc. (KRRO) Have the Potential to Rally 59.66% as Wall Street Analysts Expect?
(Zacks)
Jan-18-24 08:00AM
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio
(GlobeNewswire) -5.98%
Jan-04-24 08:00AM
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
(GlobeNewswire)
Dec-07-23 08:00AM
Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
(GlobeNewswire) -14.67%
Nov-28-23 08:00AM
Korro Bio Appoints Dr. Rachel Meyers to Board of Directors
(GlobeNewswire) +6.45%
03:31PM Loading…
Nov-03-23 03:31PM
UPDATE: Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
(GlobeNewswire) +5.94%
12:19PM
Korro Bio and Frequency Therapeutics Announce Closing of Merger and Private Placement of $117 Million
(GlobeNewswire)
Aug-10-23 04:01PM
Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results
(Business Wire)
Jul-17-23 11:59AM
Frequency (FREQ) Up 77% on Merger Deal With Korro Bio
(Zacks) -12.66%
Jul-14-23 11:22AM
Why Are Frequency Therapeutics Shares Surging Today
(Benzinga) +77.47%
06:30AM
Korro Bio and Frequency Therapeutics Announce Merger Agreement
(Business Wire)
May-12-23 04:01PM
Frequency Therapeutics Provides Business Updates and First Quarter 2023 Financial Results
(Business Wire) -5.17%
Mar-10-23 07:30AM
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
(Business Wire)
Feb-27-23 07:30AM
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
(Business Wire) +5.40%
Feb-13-23 01:55PM
Hearing loss startup to cut more than half of staff in wake of trial failure
(American City Business Journals) -80.54%
11:17AM
Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge
(Benzinga)
08:05AM
Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
(Business Wire)
Dec-19-22 07:30AM
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program
(Business Wire)
Dec-15-22 07:30AM
Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Companys Second Therapeutic Candidate for Sensorineural Hearing Loss
(Business Wire)
Nov-17-22 07:30AM
Frequency Therapeutics to Host Virtual Investor Event, Highlighting Hearing Restoration Candidate FX-322 in Advance of Q1 Clinical Results
(Business Wire) -10.05%
Nov-08-22 04:05PM
Frequency Therapeutics Provides Business Updates and Third Quarter 2022 Financial Results
(Business Wire) -9.51%
Oct-12-22 07:30AM
Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
(Business Wire) +7.47%
Aug-30-22 07:30AM
Frequency Therapeutics to Participate in September Investor and Medical Conferences
(Business Wire)
Aug-09-22 04:05PM
Frequency Therapeutics Provides Business Updates and Second Quarter 2022 Financial Results
(Business Wire) -11.11% +9.00%
Jun-24-22 09:03AM
Frequency Therapeutics (NASDAQ:FREQ) one-year losses have grown faster than shareholder returns have fallen, but the stock jumps 41% this past week
(Simply Wall St.) -7.59%
May-25-22 12:00PM
Frequency Therapeutics, Inc. (FREQ) Upgraded to Buy: What Does It Mean for the Stock?
(Zacks)
May-18-22 07:30AM
Frequency Therapeutics to Participate in 2022 H.C. Wainwright Global Investment Conference
(Business Wire) -9.02%
May-04-22 04:30PM
Frequency Therapeutics Provides Business Updates and First Quarter 2022 Financial Results
(Business Wire)
Apr-22-22 07:30AM
Frequency Therapeutics to Participate in B. Riley Securities Neuro & Ophthalmology Investor Conference
(Business Wire)
Apr-08-22 05:00PM
Frequency Exchange Corp. Virtually Closes the Market
(PR Newswire) -8.82%
Mar-15-22 07:30AM
Frequency Therapeutics Provides Business Updates and Reports Fourth Quarter and Full Year 2021 Financial Results
(Business Wire) +15.29%
Mar-10-22 06:35PM
Poseida Therapeutics, Inc. (PSTX) Beats Q4 Earnings and Revenue Estimates
(Zacks) -13.70%
Feb-28-22 07:30AM
Frequency Therapeutics to Participate in Upcoming March 2022 Investor Conferences
(Business Wire)
Jan-14-22 05:43AM
One Frequency Therapeutics, Inc. (NASDAQ:FREQ) insider upped their stake in the previous year
(Simply Wall St.)
Jan-04-22 07:30AM
Frequency Therapeutics to Present 2022 Business and Pipeline Overview at the 40th Annual J.P. Morgan Healthcare Conference
(Business Wire)
Dec-28-21 02:38AM
Destra Investment Trust Buys ThredUp Inc, Etsy Inc, Riskified, Sells , , 2U Inc
(GuruFocus.com) +5.28%
Dec-09-21 01:18PM
Frequency Therapeutics' Hearing Loss Candidate Shows Improved Speech Perception In Noise
(Benzinga)
07:30AM
Frequency Therapeutics Shares Results from FX-322-113 Severe Sensorineural Hearing Loss Study Showing Speech Perception Improvements in Noise
(Business Wire)
Nov-30-21 05:53AM
Frequency Therapeutics (NASDAQ:FREQ) investors are sitting on a loss of 81% if they invested a year ago
(Simply Wall St.)
Nov-15-21 12:25PM
Frequency Therapeutics, Inc. (FREQ) Reports Q3 Loss, Lags Revenue Estimates
(Zacks)
07:30AM
Frequency Therapeutics Provides Business Updates and Third Quarter 2021 Financial Results
(Business Wire)
Nov-09-21 07:30AM
Frequency Therapeutics Holds Virtual R&D Event Highlighting Clinical Advancement of FX-322, a New Potential Restorative Treatment for Hearing Loss and In Vivo Data for Its Remyelination Program in Multiple Sclerosis
(Business Wire)
Nov-08-21 03:00PM
Analysts Estimate Frequency Therapeutics, Inc. (FREQ) to Report a Decline in Earnings: What to Look Out for
(Zacks)
Oct-27-21 07:30AM
Frequency Therapeutics Virtual R&D Event to Detail FX-322 Clinical Advances, a New Program for Hearing Restoration and In Vivo Data from its MS Remyelination Program
(Business Wire)
Oct-21-21 07:30AM
Frequency Therapeutics Announces First Subject Dosed in FX-322 Phase 2b Acquired Sensorineural Hearing Loss (SNHL) Study and FDA Agreement on Speech Perception as Primary Endpoint
(Business Wire)
Oct-01-21 08:23AM
Do Insiders Own Lots Of Shares In Frequency Therapeutics, Inc. (NASDAQ:FREQ)?
(Simply Wall St.)
Sep-22-21 11:18AM
Frequency Therapeutics' New Data Of Hearing Loss Candidate Fails To Impress Investors
(Benzinga)
07:30AM
Frequency Therapeutics Announces New FX-322 Results Showing That Additional Study Participants Gain Hearing Improvements at Later Time Points
(Business Wire)
Sep-08-21 07:30AM
Frequency Therapeutics to Present at Upcoming Investor Conferences
(Business Wire)
Aug-30-21 05:10PM
Lifshitz Law Firm, P.C. Announces Investigations of AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), Frequency Therapeutics, Inc. (NasdaqGS: FREQ), RLX Technology Inc. (NYSE: RLX), and Washington Prime Group, Inc. (NYSE: WPG)
(ACCESSWIRE)
Aug-12-21 04:06PM
Moore Kuehn, PLLC Encourages Investors of FREQ to Contact Law Firm
(Newsfile)
08:45AM
Frequency Therapeutics, Inc. (FREQ) Reports Q2 Loss, Tops Revenue Estimates
(Zacks)
07:30AM
Frequency Therapeutics Provides Business Updates and Second Quarter 2021 Financial Results
(Business Wire)
Aug-04-21 03:00PM
Analysts Estimate Frequency Therapeutics, Inc. (FREQ) to Report a Decline in Earnings: What to Look Out for
(Zacks)
Aug-02-21 03:05PM
CLASS ACTION UPDATE for JRVR, FREQ and QFIN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
(ACCESSWIRE)
02:30PM
Final Deadline Alert: Frequency Therapeutics, Inc. (FREQ) Class Action and Last Chance for Investors to Actively Participate - Bronstein, Gewirtz & Grossman, LLC
(ACCESSWIRE)
12:30PM
SHAREHOLDER ALERT: FREQ RKT QFIN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
(ACCESSWIRE)
12:30PM
FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
(ACCESSWIRE)
11:00AM
FREQ Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Frequency Therapeutics, Inc. (FREQ) Shareholders of Class Action and Lead Plaintiff Deadline: August 2, 2021
(ACCESSWIRE)
10:00AM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FREQ, RKT and BZ
(ACCESSWIRE)
09:16AM
FREQ Final Deadline Today: Rosen, National Trial Lawyers, Encourages Frequency Therapeutics, Inc. Investors to Secure Counsel Before Important August 2 Deadline in Securities Class Action - FREQ
(Newsfile)
09:09AM
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
(Newsfile)
05:50AM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FREQ, RLX and DIDI
(ACCESSWIRE)
03:27AM
Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?
(Simply Wall St.)
Aug-01-21 10:38AM
FREQUENCY DEADLINE ALERT: Faruqi & Faruqi LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Frequency To Contact Him Directly To Discuss Their Options
(GlobeNewswire)
06:36AM
FREQ FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Frequency Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline Tomorrow in Securities Class Action - FREQ
(Newsfile)
Jul-30-21 08:49PM
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Frequency Therapeutics, Inc. and Encourages Investors to Contact the Firm
(Business Wire)
07:19PM
Frequency Therapeutics, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
(GlobeNewswire)
07:10PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FREQ
(ACCESSWIRE)
05:15PM
FREQ Final Deadline Monday: Rosen, Leading Trial Attorneys, Encourages Frequency Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important August 2 Deadline in Securities Class Action - FREQ
(Newsfile)
02:57PM
FREQ LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Frequency Therapeutics, Inc.
(Newsfile)
01:30PM
FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
(ACCESSWIRE)
12:40PM
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FREQ, OCGN and BLCT
(ACCESSWIRE)
11:30AM
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Frequency Therapeutics, Inc. (FREQ)
(Business Wire)
11:30AM
CLASS ACTION UPDATE for CCIV, FREQ and RLX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
(ACCESSWIRE)
Korro Bio, Inc. is an RNA editing company, which engages in the discovery and development of genetic medicines. The company was founded by Nessan Bermingham, Jean-Francois Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Agarwal VineetChief Financial OfficerNov 11 '24Option Exercise11.688009,344800Nov 12 07:40 PM
Agarwal VineetChief Financial OfficerNov 11 '24Sale70.0080056,0000Nov 12 07:40 PM
Agarwal VineetOfficerNov 11 '24Proposed Sale70.0080056,000Nov 12 08:28 AM
Agarwal VineetChief Financial OfficerOct 17 '24Option Exercise11.9910,216122,46810,216Oct 18 07:43 PM
Agarwal VineetChief Financial OfficerOct 17 '24Sale78.2610,216799,5270Oct 18 07:43 PM
Agarwal VineetOfficerOct 17 '24Proposed Sale78.2610,216799,527Oct 17 04:22 PM
Colletti SteveFormer OfficerOct 16 '24Proposed Sale88.6713,8211,225,450Oct 16 01:05 PM
Colletti SteveFormer OfficerAug 30 '24Proposed Sale49.2410,303507,326Aug 30 05:28 PM
New Enterprise Associates 17, 10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
BASKETT FOREST10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Florence Anthony A. Jr.10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Walker Paul Edward10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Chang Carmen10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Mathers Edward T10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Yang Rick10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Makhzoumi Mohamad10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
SANDELL SCOTT D10% OwnerApr 22 '24Buy56.0017,857999,9921,090,793Apr 24 05:00 PM
Atlas Venture Opportunity Fund10% OwnerApr 22 '24Buy56.0017,857999,992195,074Apr 23 05:23 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.